Updated Nov. 19, 2009 at 8:33 a.m.
Salix goes to market with 5.5 million shares
Post a comment
Print this blog postE-mail blog post
Share
Get the latest news alerts: Follow LTW at Twitter
Local Tech Wire
MORRISVILLE, N.C. — Drug-maker Salix Pharmaceuticals Ltd. (Nasdaq: SLXP) is offering 5.5 million new shares, the company said Wednesday. Salix set an opening price of $21 per share.
Current shares closed at $22 on Wednesday, their highest price since a stock split in 2004.
Salix said in a filing with the federal Securities and Exchange Commission that the sale will raise funds for business development and operations.
Analysts are forecasting strong sales growth over the next several financial quarters for Salix, which focuses on treatments for gastrointestinal diseases.
Jefferies & Company, Inc., is the underwriter.
Featured
Hot Off The Wire
- Hot Off the Wire – Apple charges $107 for iPad batteries; Amazon drops Colorado affiliates like it did in N.C.; Facebook expands in India
- Hot Off the Wire – $5M bonus for Apple exec; Disney to shut studio, cut 450 jobs; Motorola co-CEO’s pay $3.77M; Adobe CEO pay plunges 68%
- Hot Off the Wire – No ‘xxx’ domains yet, Net agency says; Analyst ups Google stock value; Vin Gupta leaves InfoGroup board
E-mail Preferences
The Skinny
- N.C. Treasurer set to unveil $250M Innovation Fund manager
- Another 202 layoffs at IBM push latest count above 2,900
- ‘Social media is a beast’ – So how can your business tame it?
- In tough climate, GSK dedicates plant to fight elephantiasis
- ‘Who’s Cisco?’ New RTP site exec recalls a humble birth
- Google, N.C.? UNC-CH, Carrboro, Chapel Hill want Google Net
- Tweet this from Epic: Three more hints about Gears 3
- ‘The Daily Me’: You want your news mobile, instantly from several sources
- ‘Gears 3’ rumors grow louder – Epic president dropping hints
- Intel-ligent boost for tech – Intel, VCs launch investment alliance

